Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone densitometry: is it a real clinical contribution?]

E Arteaga1

  • 1Departamento de Endocrinología, Metabolismo y Nutrición, Hospital Clínico Universidad Católica, Santiago de Chile.

Revista Medica De Chile
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of bilateral oophorectomy and menopause hormone therapy with mild cognitive impairment: the REDLINC X study.

Climacteric : the journal of the International Menopause Society·2021
Same author

Ovarian thecoma: A very unusual cause of postmenopausal bleeding.

Post reproductive health·2021
Same author

Gender differences in the prevalence of vitamin D deficiency in a southern Latin American country: a pilot study.

Climacteric : the journal of the International Menopause Society·2020
Same author

Muscle health in Hispanic women. REDLINC VIII.

Climacteric : the journal of the International Menopause Society·2019
Same author

Postmenopausal androgen-secreting ovarian tumors: challenging differential diagnosis in two cases.

Climacteric : the journal of the International Menopause Society·2019
Same author

Risk factors of long-term mortality in middle-aged women: a 27-year follow-up cohort.

Climacteric : the journal of the International Menopause Society·2018
Same journal

[Health Education for Informed Autonomy: When to Begin?]

Revista medica de Chile·2026
Same journal

[Open Atrial Transcatheter Mitral Valve Replacement for Mitral Annular Calcification: First Case Report in Chile].

Revista medica de Chile·2026
Same journal

[From Opinion to Structure: The Role of Different Types of Systematic Reviews Within the Evidence Synthesis Ecosystem].

Revista medica de Chile·2026
Same journal

[Neuropsychiatric Effects of Creatine: What Does the Preclinical and Clinical Evidence Conclude?]

Revista medica de Chile·2026
Same journal

[Ethical Issues in Early Serological Diagnosis of Alzheimer's Disease].

Revista medica de Chile·2026
Same journal

[Weight Recurrence After Bariatric Surgery: Definitions, Diagnosis, and Management Strategies. Part 1].

Revista medica de Chile·2026
See all related articles

Early detection of osteoporosis is crucial, especially for women over 50. Bone density testing offers precise measurements for clinical use, aiding in the identification of silent bone loss.

Area of Science:

  • Osteoporosis research
  • Medical imaging technologies

Context:

  • Osteoporosis is a prevalent condition, particularly in postmenopausal women.
  • Early detection is vital as osteoporosis is often asymptomatic and irreversible.
  • Current guidelines from the National Osteoporosis Foundation suggest specific indications for bone density testing.

Purpose:

  • To highlight the clinical utility of bone absorptiometry in osteoporosis diagnosis.
  • To discuss the precision and applicability of radiological dual-photon absorptiometry.
  • To advocate for revised screening recommendations for postmenopausal women.

Summary:

  • Bone absorptiometry, particularly radiological dual-photon absorptiometry, provides precise bone density measurements (near 1% precision).
  • This technology is essential for the early detection of osteoporosis, a silent disease.

Related Experiment Videos

  • Despite current guidelines, the high prevalence of asymptomatic osteopenia in postmenopausal women suggests a need for routine screening.

    • Impact:

    • Improved diagnostic accuracy for osteoporosis.
    • Potential for earlier intervention and management of bone density loss.
    • Informing future clinical practice guidelines for osteoporosis screening in at-risk populations.